美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

艾伯维公司

193.21

+1.720.90%

成交量：90.09万

成交额：1.73亿

市值：3,412.80亿

市盈率：82.57

高：193.59

开：192.01

低：191.36

收：191.49

数据加载中...

总览公司新闻公告

启德医药ADC平台就21款药物达成130亿美元交易；艾伯维16亿美元押注分子胶降解剂...

达成超16亿美元合作！艾伯维(ABBV.US)重金押注分子胶降解剂

艾伯维上涨1.4%，报173.97美元/股

强生艾伯维的CNS分歧

生物制药小编

艾伯维下跌1.27%，报171.495美元/股

更新 1-美国针对诺和诺德的 Ozempic 和 Wegovy 进行医疗保险价格谈判

众多仿制药冲击之下艾伯维(ABBV.US)“昔日药王”修美乐份额仍遥遥领先

更新版 1-艾伯维首席执行官表示，艾伯维计划 "减少 "对精神科药物的资金投入

艾伯维首席执行官表示将 "减少 "对精神科药物的资金投入

艾伯维下跌1.24%，报174.55美元/股

首款狂犬病双抗在国内报上市、先声再明三抗新药授权艾伯维、默沙东 PD-1 单抗在国内获批新适应症

医药经济报

先声再明就多发性骨髓瘤候选药物与艾伯维达成开发许可选择协议

10.55亿美元！先声再明与艾伯维就多发性骨髓瘤三抗候选创新药开发达成合作

先声药业与AbbVie达成SIM0500海外许可协议，最高可获10.55亿美元付款

中国先声药业授予艾伯维血癌候选药物许可权

先声药业与AbbVie就SIM0500订立海外许可选择权协议

【先声药业(02096.HK)附属与AbbVie就SIM0500订立海外许可选择权协议】先声药业(02096.HK)公布，于2025年1月13日，该集团附属公司山东先声生物制药有限公司(山东先声)与AbbVie Inc.(股票代码：ABBV)的附属公司订立许可选择权协议。根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤(MM)患者进行临床I期研究。

2025年买什么？从电动车到美妆，策略师看好四大潜力股

BUZZ-贝伦贝格称，肥胖症药物和并购是 2025 年制药业的主要驱动力

艾伯维下调2024财年盈测低于市场预期

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ABBV/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABBV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":193.2063,"timestamp":1749741167057,"preClose":191.485,"halted":0,"volume":900916,"delay":0,"floatShares":1762776778,"shares":1766403027,"eps":2.339923,"marketStatus":"交易中","change":1.7213,"latestTime":"06-12 11:12:48 EDT","open":192.01,"high":193.5896,"low":191.3624,"amount":173443654.61468,"amplitude":0.011631,"askPrice":193.22,"askSize":218,"bidPrice":193.06,"bidSize":33,"shortable":3,"etf":0,"ttmEps":2.339923,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1749758400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":191.485,"dividendRate":0.033022,"preHourTrading":{"tag":"盘前","latestPrice":192.07,"preClose":191.485,"latestTime":"09:29 EDT","volume":552,"amount":105760.64424,"timestamp":1749734997063},"postHourTrading":{"tag":"盘后","latestPrice":191.25,"preClose":191.5,"latestTime":"19:59 EDT","volume":231445,"amount":44321692.88805,"timestamp":1749686370755},"volumeRatio":0.824625,"impliedVol":0.2779,"impliedVolPercentile":0.56},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","floatShares":1762776778,"roa":"8.34%","roe":"88.40%","lyrEps":2.395703,"volumeRatio":0.824625,"shares":1766403027,"dividePrice":6.38,"high":193.5896,"amplitude":0.011631,"preClose":191.485,"low":191.3624,"week52Low":163.52,"pbRate":"240.34","psRate":"5.95","week52High":218.66,"institutionHeld":0,"latestPrice":193.2063,"committee":-0.737052,"eps":2.339923,"divideRate":0.033022,"volume":900916,"delay":0,"ttmEps":2.339923,"open":192.01,"prevYearClose":177.7,"prevWeekClose":189.83,"prevMonthClose":186.11,"prevQuarterClose":209.52,"fiveDayClose":187.47,"twentyDayClose":177.44,"sixtyDayClose":213.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABBV\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506828773","title":"启德医药ADC平台就21款药物达成130亿美元交易；艾伯维16亿美元押注分子胶降解剂...","url":"https://stock-news.laohu8.com/highlight/detail?id=2506828773","media":"新康界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506828773?lang=zh_cn&edition=fundamental","pubTime":"2025-01-25 14:25","pubTimestamp":1737786307,"startTime":"0","endTime":"0","summary":"启德医药与Biohaven签署了两项战略合作协议。根据第一项协议，Biohaven将获得启德医药与AimedBio联合开发的FGFR3靶点同类首创ADC药物的全球开发和商业化权益。Neomorph将从AbbVie获得预付款，并有资格获得高达16.4亿美元的期权费和里程碑，以及净销售额的分层特许权使用费。2024年2月与诺和诺德达成14.6亿美元多靶点研发合作协议，发现用于心脏代谢和罕见疾病的新型分子胶降解剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125142604abb7ff4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125142604abb7ff4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BGHQF631.EUR","LU1003077747.HKD","LU0234570918.USD","DC","LU0158827948.USD","LU1291159041.SGD","LU1983299246.USD","LU0985320562.USD","LU1496350502.SGD","LU0861579265.USD","LU1585245621.USD","LU0820561909.HKD","LU1934455277.USD","SG9999015952.SGD","SG9999015986.USD","LU2237443382.USD","LU1244550221.USD","LU1037948541.HKD","LU0198837287.USD","BK4533","BK4550","LU1496350171.SGD","BK4559","LU1267930573.SGD","LU1093756325.SGD","ABBV","LU0708994859.HKD","LU0310800379.SGD","IE00B4R5TH58.HKD","IE0004445239.USD","LU0882574055.USD","LU0029864427.USD","IE00BJJMRZ35.SGD","LU0545039389.USD","LU1023059063.AUD","LU1244550577.SGD","LU1551013342.USD","LU0738911758.USD","LU0689472784.USD","LU2237443465.HKD","BK4588","BK4534","IE0002141913.USD","LU0234572021.USD","LU0256863811.USD","BK4566","LU0661504455.SGD","BK4581","LU0553294199.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2505885338","title":"达成超16亿美元合作！艾伯维(ABBV.US)重金押注分子胶降解剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2505885338","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505885338?lang=zh_cn&edition=fundamental","pubTime":"2025-01-24 14:36","pubTimestamp":1737700577,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1 月 24 日，艾伯维与 Neomorph 宣布达成一项合作与许可选择协议，以共同开发针对肿瘤学和免疫学多个靶点的新型分子胶降解剂。根据协议条款，Neomorph 将从艾伯维获得一笔预付款，并有资格获得高达 16.4 亿美元的总额期权费和里程碑费，以及净销售额的分级特许权使用费。Insight 数据库显示，除了与 Neomorph 达成的合作，自2025年起，艾伯维还通过多项合作深化了神经系统疾病、肿瘤领域的布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1243236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"达成超16亿美元合作！艾伯维(ABBV.US)重金押注分子胶降解剂","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","LU0203345920.USD","LU1989771016.USD","IE0009355771.USD","IE0002141913.USD","LU2237443382.USD","LU1934455863.HKD","LU2237443895.HKD","SG9999001440.SGD","IE00BVYPNV92.GBP","LU0114720955.EUR","LU0122379950.USD","ABBV","LU2089283258.USD","LU1037948541.HKD","LU0738911758.USD","LU1037948897.HKD","SG9999015986.USD","LU1551013425.SGD","IE00BJT1NW94.SGD","LU0029864427.USD","IE0004445239.USD","LU0689472784.USD","SG9999015952.SGD","LU0310800379.SGD","LU0198837287.USD","LU0985320562.USD","LU0256863811.USD","LU2089984988.USD","BK4139","LU1023059063.AUD","LU1291159041.SGD","BK4566","LU0256863902.USD","LU1093756168.USD","BK4585","LU0795875169.SGD","LU1839511570.USD","LU2237443622.USD","LU1732799900.SGD","LU1934455277.USD","LU1934455194.USD","LU1244550221.USD","LU1983299246.USD","SG9999003800.SGD","LU2133065610.SGD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1267930573.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2505160271","title":"艾伯维上涨1.4%，报173.97美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2505160271","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505160271?lang=zh_cn&edition=fundamental","pubTime":"2025-01-21 22:34","pubTimestamp":1737470066,"startTime":"0","endTime":"0","summary":"1月21日，艾伯维(ABBV)开盘上涨1.4%，截至22:34，报173.97美元/股，成交3420.39万美元。财务数据显示，截至2024年09月30日，艾伯维收入总额412.32亿美元，同比增长3.04%；归母净利润43.0亿美元，同比增长6.41%。大事提醒：1月31日，艾伯维将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224019986e34ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224019986e34ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","LU2089283258.USD","IE00BVYPNV92.GBP","IE00B2B36J28.USD","IE0009355771.USD","LU1003077747.HKD","IE00BSNM7G36.USD","LU0256863811.USD","LU0545039389.USD","LU1057294990.SGD","LU2133065610.SGD","SG9999001440.SGD","LU1037948897.HKD","SG9999015978.USD","SG9999015986.USD","LU1983299246.USD","LU0114720955.EUR","LU0310799852.SGD","SG9999015952.SGD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU1244550494.USD","LU1496350171.SGD","BK4139","BK4588","LU2237443382.USD","LU1989772840.SGD","LU1934455277.USD","SG9999011175.SGD","BK4585","LU1244550221.USD","LU2089984988.USD","ABBV","SG9999015945.SGD","LU0256863902.USD","LU1496350502.SGD","LU0965509010.AUD","LU0234570918.USD","LU1718418525.SGD","LU0203345920.USD","IE0002141913.USD","LU0965509101.SGD","LU1093756325.SGD","LU0708994859.HKD","BK4533","LU1430594728.SGD","LU0861579265.USD","LU2087621335.USD","LU0456855351.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2504434404","title":"强生艾伯维的CNS分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=2504434404","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504434404?lang=zh_cn&edition=fundamental","pubTime":"2025-01-19 10:20","pubTimestamp":1737253230,"startTime":"0","endTime":"0","summary":"态度的巨大差异也反映出，在CNS领域，跨国大药企们已产生明显分歧。2023年年底，艾伯维宣布以87亿美元收购Cerevel，后者的核心管线是毒蕈碱受体M4的选择性正变构调节剂emraclidine，这是精神分裂症领域的潜在突破选手。因此，在2025年JPM大会上，尽管艾伯维高管表示，公司仍然愿意承担“经过计算的风险”，但同时也明确表示，对于早期CNS资产的重大投资，会更加谨慎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250119105449a2273dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250119105449a2273dd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABBV","BK4592","LU0114720955.EUR","LU0203345920.USD","IE0034235303.USD","LU1935042991.SGD","LU1244550577.SGD","LU1894683348.USD","LU0889566641.SGD","CNS","IE00B3PB1722.GBP","LU0345769128.USD","LU0098860793.USD","LU1506573853.SGD","IE00B7SZLL34.SGD","BK4588","LU1732800096.USD","LU1061106388.HKD","LU1244550221.USD","SG9999002224.SGD","BK4532","LU0466842654.USD","LU1032466523.USD","IE0002270589.USD","IE0002141913.USD","LU1929549753.HKD","LU2089984988.USD","JNJ","LU1221951129.SGD","LU0912757837.SGD","IE00BSNM7G36.USD","BK4581","BK4585","BK4504","SG9999002232.USD","LU0345770993.USD","IE00BVYPNV92.GBP","BK4534","LU0640476718.USD","LU1057294990.SGD","LU0058720904.USD","LU1894683264.USD","LU1074936037.SGD","BK4568","LU1674673691.USD","BK4550","BK4559","LU1066053197.SGD","IE00BVYPNW00.USD","LU1162221912.USD","LU0345770308.USD"],"gpt_icon":0},{"id":"2504297115","title":"艾伯维下跌1.27%，报171.495美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2504297115","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504297115?lang=zh_cn&edition=fundamental","pubTime":"2025-01-18 03:41","pubTimestamp":1737142861,"startTime":"0","endTime":"0","summary":"1月18日，艾伯维(ABBV)盘中下跌1.27%，截至03:41，报171.495美元/股，成交5.93亿美元。财务数据显示，截至2024年09月30日，艾伯维收入总额412.32亿美元，同比增长3.04%；归母净利润43.0亿美元，同比增长6.41%。大事提醒：1月31日，艾伯维将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180344359607d7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180344359607d7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443622.USD","LU1023059063.AUD","LU0456855351.SGD","LU1093756168.USD","LU2237443978.SGD","SG9999015952.SGD","LU0310799852.SGD","LU1983299246.USD","LU1244550494.USD","LU2023251221.USD","LU0965508806.USD","LU1291159041.SGD","LU0949170772.SGD","IE00BFTCPJ56.SGD","LU0545039389.USD","LU2347655156.SGD","LU2237443382.USD","LU0170899867.USD","BK4139","LU1061106388.HKD","SG9999015986.USD","LU1989771016.USD","LU0198837287.USD","LU0795875086.SGD","LU1732800096.USD","ABBV","LU2089283258.USD","BK4588","LU0158827948.USD","LU1989772840.SGD","LU2133065610.SGD","LU0211327993.USD","LU2112291526.USD","LU0965509101.SGD","LU1934455863.HKD","LU2089284900.SGD","LU0965509010.AUD","LU1551013425.SGD","LU2089984988.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU0795875169.SGD","LU0738911758.USD","LU0912757837.SGD","BK4550","LU0211328371.USD","IE00B2B36J28.USD","LU2087621335.USD","LU1934455194.USD","LU0985320562.USD"],"gpt_icon":0},{"id":"2504504151","title":"更新 1-美国针对诺和诺德的 Ozempic 和 Wegovy 进行医疗保险价格谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2504504151","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504504151?lang=zh_cn&edition=fundamental","pubTime":"2025-01-17 21:05","pubTimestamp":1737119138,"startTime":"0","endTime":"0","summary":"     路透华盛顿1月17日 - 美国政府周五表示，诺和诺德公司的  糖尿病治疗药物Ozempic和减肥治疗药物Wegovy是2027年医疗保险价格谈判的15种目标药物之一。其他上榜药物包括辉瑞  的抗癌药Ibrance和Xtandi、葛兰素史克  的哮喘和慢性阻塞性肺病 治疗药物Trelegy Ellipta、梯瓦  的亨廷顿氏病治疗药物Austedo和艾伯维  的肠易激综合征治疗药物Linzess。所选药品的生产商将在 2 月 28 日前决定是否参加谈判。这 15 种新药是第二批进入该程序的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU1291159041.SGD","LU1983299246.USD","LU0114720955.EUR","LU0128525929.USD","LU0985320562.USD","LU0795875086.SGD","SG9999002224.SGD","LU1551013425.SGD","LU2237443382.USD","PFE","LU1066053197.SGD","LU1267930490.SGD","SG9999015945.SGD","LU1037948541.HKD","LU0225284248.USD","LU0965508806.USD","LU1496350171.SGD","BK4559","LU1093756325.SGD","LU1894683264.USD","BK4599","ABBV","LU0708994859.HKD","IE00B4R5TH58.HKD","LU0912757837.SGD","LU2089984988.USD","LU0882574055.USD","IE0009355771.USD","SGXZ57979304.SGD","LU1894683348.USD","LU0943347566.SGD","LU1057294990.SGD","BK4568","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU1244550494.USD","LU1883839398.USD","LU1989771016.USD","LU2468319806.SGD","NVO","BK4534","BK4585","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4566","SG9999015978.USD","LU0289739699.SGD","LU0965509010.AUD","LU0203345920.USD"],"gpt_icon":1},{"id":"2504906466","title":"众多仿制药冲击之下 艾伯维(ABBV.US)“昔日药王”修美乐份额仍遥遥领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2504906466","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504906466?lang=zh_cn&edition=fundamental","pubTime":"2025-01-17 11:52","pubTimestamp":1737085927,"startTime":"0","endTime":"0","summary":"尽管截至2024年2月，艾伯维修美乐仍以96%的市场份额保持其主导地位，但随着CVS Health等大型药品与药房福利管理机构将该品牌药从主要药品处方集中彻底移除，修美乐的市场领导地位在2024年5月受到了威胁，市场份额降至77%，但仍然占据阿达木单抗市场的绝对主导地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"众多仿制药冲击之下 艾伯维(ABBV.US)“昔日药王”修美乐份额仍遥遥领先","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1291159041.SGD","IE00BVYPNV92.GBP","LU0029864427.USD","SG9999015986.USD","LU0122379950.USD","LU1551013425.SGD","LU1061106388.HKD","LU1732799900.SGD","IE0009355771.USD","LU0211328371.USD","LU0198837287.USD","LU1934455863.HKD","LU0738911758.USD","LU1267930490.SGD","LU0170899867.USD","LU1839511570.USD","BK4585","LU0949170772.SGD","LU2237443895.HKD","LU2237443978.SGD","SG9999011175.SGD","LU0234572021.USD","SG9999003800.SGD","LU1496350502.SGD","LU1037948897.HKD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU0965509283.SGD","LU1093756325.SGD","LU2089284900.SGD","IE00B3PB1722.GBP","LU0310800379.SGD","LU1983299246.USD","LU2237443382.USD","SG9999015978.USD","ABBV","LU1244550221.USD","LU2237443622.USD","LU0965509010.AUD","LU2089984988.USD","LU1585245621.USD","LU1934455277.USD","LU0158827948.USD","LU0456855351.SGD","LU2347655156.SGD","LU2237443465.HKD","IE00B42XCP33.USD","BK4139","LU0689472784.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2503295627","title":"更新版 1-艾伯维首席执行官表示，艾伯维计划 \"减少 \"对精神科药物的资金投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2503295627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503295627?lang=zh_cn&edition=fundamental","pubTime":"2025-01-16 01:26","pubTimestamp":1736962002,"startTime":"0","endTime":"0","summary":"     路透1月15日 - 艾伯维  首席执行官罗伯特-迈克尔周三在一次行业会议上表示，公司将 \"减少 \"对精神疾病实验药物的投入。这番话是在其试验性精神分裂症药物在两项中期研究中失败几个月后说的。\"迈克尔补充说：\"我们可以减少资金投入，尤其是在心理方面，但这并不会改变我们承担经过深思熟虑的风险的意愿。艾伯维表示，它将记录一笔与该药物有关的约35亿美元的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU1983299246.USD","LU0234570918.USD","LU1061106388.HKD","LU2133065610.SGD","SG9999015986.USD","BK4566","LU1003077747.HKD","LU0170899867.USD","IE00BJJMRZ35.SGD","LU1244550494.USD","LU1093756325.SGD","LU0256863811.USD","LU0820561818.USD","LU1839511570.USD","LU0965509010.AUD","LU2089284900.SGD","LU0122379950.USD","LU0198837287.USD","LU2237443465.HKD","LU2237443382.USD","SG9999001440.SGD","LU1934455194.USD","IE00BGHQF631.EUR","LU0114720955.EUR","LU0545039389.USD","LU1934455863.HKD","LU1989771016.USD","LU0738911758.USD","LU1244550221.USD","LU0456855351.SGD","LU2237443549.SGD","LU0029864427.USD","LU0234572021.USD","IE00BVYPNV92.GBP","LU1267930490.SGD","LU1989772840.SGD","ABBV","LU2237443622.USD","LU2087621335.USD","LU1057294990.SGD","LU1430594728.SGD","BK4533","IE00B42XCP33.USD","BK4581","LU1585245621.USD","LU2237443895.HKD","LU0985320562.USD","LU1934455277.USD","LU0256863902.USD"],"gpt_icon":0},{"id":"2503462227","title":"艾伯维首席执行官表示将 \"减少 \"对精神科药物的资金投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2503462227","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503462227?lang=zh_cn&edition=fundamental","pubTime":"2025-01-16 01:08","pubTimestamp":1736960915,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透1月15日 - 艾伯维公司  首席执行官罗伯特-迈克尔（Robert Michael）周三在一次行业会议上表示，将减少对精神疾病实验药物的资金投入。 这番话是在实验性精神分裂症药物在两项中期研究中失败几个月后说的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1023059063.AUD","IE00BVYPNW00.USD","LU0234572021.USD","LU0545039389.USD","LU1839511570.USD","LU2237443895.HKD","LU1244550494.USD","LU1732800096.USD","LU1003077747.HKD","LU1267930490.SGD","LU1989771016.USD","BK4534","LU0661504455.SGD","LU1037948541.HKD","LU0949170772.SGD","LU0965508806.USD","LU1496350502.SGD","LU0708994859.HKD","SG9999015986.USD","LU1061106388.HKD","LU1057294990.SGD","LU0256863902.USD","LU1244550577.SGD","IE0009355771.USD","LU2237443549.SGD","LU0985320562.USD","ABBV","LU1037948897.HKD","LU2237443978.SGD","LU1718418525.SGD","LU1934455277.USD","LU2023251221.USD","BK4533","LU0553294199.USD","LU2237443622.USD","LU1585245621.USD","LU0128525929.USD","LU0122379950.USD","LU0965509283.SGD","LU0912757837.SGD","LU0211327993.USD","LU1983299246.USD","LU1496350171.SGD","LU0820561818.USD","LU2089984988.USD","IE00BJT1NW94.SGD","BK4585","LU1934455194.USD","LU1989772923.USD"],"gpt_icon":0},{"id":"2503508756","title":"艾伯维下跌1.24%，报174.55美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2503508756","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503508756?lang=zh_cn&edition=fundamental","pubTime":"2025-01-15 00:04","pubTimestamp":1736870649,"startTime":"0","endTime":"0","summary":"1月15日，艾伯维(ABBV)盘中下跌1.24%，截至00:04，报174.55美元/股，成交1.74亿美元。财务数据显示，截至2024年09月30日，艾伯维收入总额412.32亿美元，同比增长3.04%；归母净利润43.0亿美元，同比增长6.41%。大事提醒：1月31日，艾伯维将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001008960390db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001008960390db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0203347892.USD","LU1061106388.HKD","IE00BSNM7G36.USD","LU0965508806.USD","BK4534","LU1430594728.SGD","ABBV","LU1989771016.USD","LU2023251221.USD","LU1244550221.USD","LU0965509101.SGD","LU1037948541.HKD","LU1291159041.SGD","LU2089284900.SGD","LU1037948897.HKD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1934455863.HKD","LU0738911758.USD","LU2089283258.USD","LU1057294990.SGD","LU1989772923.USD","LU1003077747.HKD","LU0256863902.USD","LU1551013425.SGD","BK4566","IE00B42XCP33.USD","LU2087621335.USD","LU1093756325.SGD","LU2237443549.SGD","SG9999001440.SGD","IE0009355771.USD","IE00BVYPNW00.USD","LU0553294199.USD","LU0882574055.USD","LU0128525929.USD","LU1023059063.AUD","LU2237443978.SGD","LU2112291526.USD","LU1267930490.SGD","BK4559","IE00BFTCPJ56.SGD","LU0965509010.AUD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1934455194.USD","LU1267930573.SGD","LU1934455277.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2503833540","title":"首款狂犬病双抗在国内报上市、先声再明三抗新药授权艾伯维、默沙东 PD-1 单抗在国内获批新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2503833540","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503833540?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 18:17","pubTimestamp":1736849828,"startTime":"0","endTime":"0","summary":"智翔金泰狂犬病双抗在国内报上市今日，CDE 官网显示，智翔金泰 1 类新药“斯乐韦米单抗”在国内报上市。斯乐韦米单抗主要开发用于疑似狂犬病病毒 III 级暴露后的被动免疫。值得注意的是，该药也是狂犬病领域首款且目前唯一的双抗药物。根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。至此，帕博利珠单抗在中国获批的适应症已经达到 19 个。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114183403abaa6dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114183403abaa6dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU1974910355.USD","LU2106854487.HKD","PD","LU0158827948.USD","IE00BN8TJ469.HKD","LU0320765646.SGD","LU1496350502.SGD","LU0861579265.USD","LU1169589451.USD","LU0820561909.HKD","SG9999015952.SGD","SG9999001176.SGD","LU1244550221.USD","SG9999015945.SGD","MRK","IE00BJT1NW94.SGD","LU1496350171.SGD","LU1699723380.USD","ABBV","SG9999013999.USD","LU0310800379.SGD","IE00BVYPNV92.GBP","IE00B4R5TH58.HKD","IE0004445239.USD","LU0912757837.SGD","LU2089984988.USD","LU0456855351.SGD","SG9999014567.USD","LU0545039389.USD","LU1244550577.SGD","LU1551013342.USD","SGXZ57979304.SGD","LU1571399168.USD","LU1941712264.USD","LU2237443978.SGD","LU0738911758.USD","LU2461242641.AUD","LU1244550494.USD","SG9999015358.SGD","LU0203347892.USD","BK4534","LU0234572021.USD","IE00BLSP4239.USD","LU0965509101.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU0965509010.AUD","LU0203345920.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2503651596","title":"先声再明就多发性骨髓瘤候选药物与艾伯维达成开发许可选择协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2503651596","media":"红星新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503651596?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 11:37","pubTimestamp":1736825820,"startTime":"0","endTime":"0","summary":"红星资本局1月14日消息，1月13日，先声药业集团 旗下抗肿瘤创新药公司先声再明宣布，已与全球制药公司艾伯维就先声再明正在中美两国进行临床I期研究的多发性骨髓瘤候选药物SIM0500达成开发许可选择协议。资料配图 图据视觉中国根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。多发性骨髓瘤是第二大血液瘤，可以影响多个器官和组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501141138039602e5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501141138039602e5f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1989771016.USD","LU1244550577.SGD","LU2347655156.SGD","BK4559","LU2237443895.HKD","LU2023251221.USD","LU0256863811.USD","LU0882574055.USD","LU0949170772.SGD","LU1037948541.HKD","LU2087621335.USD","LU2089283258.USD","IE00B42XCP33.USD","LU2089984988.USD","LU0234572021.USD","LU1496350502.SGD","LU0128525929.USD","LU0861579265.USD","LU0545039389.USD","LU0965509010.AUD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0965509101.SGD","LU0310800379.SGD","IE00BDGV0183.EUR","LU0965508806.USD","LU0198837287.USD","LU1003077747.HKD","LU1718418525.SGD","LU0170899867.USD","BK4588","LU2237443382.USD","BK4566","BK4550","SG9999015978.USD","LU2237443549.SGD","LU1732800096.USD","LU0661504455.SGD","LU1093756168.USD","LU0553294199.USD","ABBV","LU1023059063.AUD","IE00B2B36J28.USD","SG9999015945.SGD","LU0795875169.SGD","LU0965509283.SGD","LU1732799900.SGD","LU1496350171.SGD","LU0234570918.USD","BK4139"],"gpt_icon":0},{"id":"2503564609","title":"10.55亿美元！先声再明与艾伯维就多发性骨髓瘤三抗候选创新药开发达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2503564609","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503564609?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 09:38","pubTimestamp":1736818688,"startTime":"0","endTime":"0","summary":"2025年1月13日，先声药业集团旗下抗肿瘤创新药公司先声再明与全球生物制药公司艾伯维宣布，双方已就先声再明的在研候选药物SIM0500达成许可选择协议。SIM0500目前正在中美两国开展针对复发或难治性多发性骨髓瘤的临床I期研究。根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。多发性骨髓瘤是第二大血液瘤，可以影响多个器官和组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140941199602c47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140941199602c47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509101.SGD","LU1551013425.SGD","LU2237443382.USD","IE00BVYPNW00.USD","LU0882574055.USD","LU1244550577.SGD","LU1934455194.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU0943347566.SGD","LU0198837287.USD","LU1989771016.USD","BK4559","LU0985320562.USD","LU1551013342.USD","BK4534","LU0795875086.SGD","LU0661504455.SGD","LU0203347892.USD","LU1244550494.USD","LU2237443895.HKD","LU0234570918.USD","LU0029864427.USD","LU1934455863.HKD","LU2133065610.SGD","LU0965509283.SGD","LU1585245621.USD","ABBV","SG9999015952.SGD","IE00BFTCPJ56.SGD","LU0965509010.AUD","IE00B3PB1722.GBP","LU1732800096.USD","LU0861579265.USD","LU0912757837.SGD","LU1057294990.SGD","LU0211328371.USD","LU1093756325.SGD","LU1718418525.SGD","IE00BDGV0183.EUR","LU0158827948.USD","LU1839511570.USD","LU1983299246.USD","LU0114720955.EUR","LU1003077747.HKD","IE00BVYPNV92.GBP","LU0689472784.USD","LU1061106388.HKD","LU0310800379.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2503564677","title":"先声药业与AbbVie达成SIM0500海外许可协议，最高可获10.55亿美元付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2503564677","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503564677?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 09:35","pubTimestamp":1736818503,"startTime":"0","endTime":"0","summary":"财中社1月14日电先声药业 发布公告，与AbbVie签订了关于研究性新候选药物SIM0500的海外许可选择权协议。根据协议，AbbVie将获得SIM0500的许可选择性权益，该药物目前正在中美两国针对复发或难治性多发性骨髓瘤患者进行临床I期研究。公司将从AbbVie收取首付款，以及最高10.55亿美元的选择性权益付款和里程碑付款。文章来源：财中社先声药业与AbbVie达成SIM0500海外许可协议，最高可获10.55亿美元付款","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114094641aba9d54f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114094641aba9d54f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","ABBV","LU1057294990.SGD","LU1989771016.USD","LU0234570918.USD","LU0882574055.USD","LU1244550577.SGD","LU1983299246.USD","LU0114720955.EUR","LU0689472784.USD","LU1061106388.HKD","LU1093756325.SGD","BK4534","LU2237443382.USD","LU1551013342.USD","LU0198837287.USD","IE00BDGV0183.EUR","IE00B3PB1722.GBP","LU1839511570.USD","LU0211328371.USD","IE00BFTCPJ56.SGD","LU0912757837.SGD","LU0943347566.SGD","LU2237443895.HKD","LU1551013425.SGD","LU1934455194.USD","LU0985320562.USD","LU1585245621.USD","BK4559","LU0965509101.SGD","LU0029864427.USD","LU0203347892.USD","LU1003077747.HKD","LU1718418525.SGD","LU1934455863.HKD","LU1244550494.USD","IE00BVYPNW00.USD","IE00BVYPNV92.GBP","LU0795875086.SGD","LU0158827948.USD","LU1732800096.USD","LU0965509010.AUD","SG9999015952.SGD","LU0310800379.SGD","LU0965509283.SGD","LU1093756168.USD","LU0861579265.USD","LU2133065610.SGD","LU0661504455.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2503005613","title":"中国先声药业授予艾伯维血癌候选药物许可权","url":"https://stock-news.laohu8.com/highlight/detail?id=2503005613","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503005613?lang=zh_cn&edition=fundamental","pubTime":"2025-01-13 22:13","pubTimestamp":1736777596,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透1月13日 - 先声药业  周一称，该公司已授予美国制药商艾伯维  在中国以外地区许可其血癌新药候选药物的选择权。根据协议，艾伯维将向先声药业支付高达10.6亿美元的费用，以及在中国境外销售的特许权使用费。艾伯维将从中国境内的销售中收取特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","LU0256863811.USD","BK4588","LU1551013425.SGD","BK4566","IE00BVYPNW00.USD","LU0820561818.USD","02096","BK4581","LU1267930490.SGD","IE00BDGV0183.EUR","LU0170899867.USD","IE0004445239.USD","LU2089283258.USD","LU0545039389.USD","LU0795875169.SGD","BK4585","LU2468319806.SGD","SG9999011175.SGD","IE00BJT1NW94.SGD","LU1093756168.USD","SG9999003800.SGD","LU0417517546.SGD","LU1989772923.USD","LU1267930573.SGD","LU0943347566.SGD","LU1244550494.USD","LU1496350171.SGD","LU1934455194.USD","BK4533","IE00B2B36J28.USD","LU2089284900.SGD","IE00B3PB1722.GBP","LU0912757837.SGD","LU0553294199.USD","LU1551013342.USD","LU1983299246.USD","ABBV","LU1244550221.USD","LU2087621335.USD","LU1585245621.USD","LU1934455277.USD","LU0158827948.USD","LU1057294990.SGD","LU0128525929.USD","SG9999001440.SGD","LU0965509101.SGD","IE00B42XCP33.USD","LU0689472784.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2503300920","title":"先声药业与AbbVie就SIM0500订立海外许可选择权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2503300920","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503300920?lang=zh_cn&edition=fundamental","pubTime":"2025-01-13 21:59","pubTimestamp":1736776784,"startTime":"0","endTime":"0","summary":"根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤患者进行临床I期研究。根据该协议条款，集团将从Abb Vie收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。Abb Vie有权就大中华地区净销售额收取分级特许权使用费。SIM0500通过多种抗肿瘤机制，表现出了针对MM细胞的强大T细胞毒性效应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132159449864ce2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132159449864ce2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0738911758.USD","LU0795875086.SGD","LU2347655156.SGD","SG9999015952.SGD","LU2237443895.HKD","LU1003077747.HKD","LU0882574055.USD","SG9999015945.SGD","LU1551013342.USD","LU2237443549.SGD","LU0861579265.USD","LU0949170772.SGD","SG9999015986.USD","LU1934455863.HKD","BK4139","LU0943347566.SGD","LU2089984988.USD","02096","BK4534","SG9999003800.SGD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU1093756325.SGD","IE0009355771.USD","IE00B3PB1722.GBP","BK4559","LU1267930490.SGD","LU0198837287.USD","IE00BVYPNW00.USD","LU1023059063.AUD","LU2087621335.USD","LU0114720955.EUR","LU1989772923.USD","LU0203347892.USD","IE00BDGV0183.EUR","LU0122379950.USD","IE00B2B36J28.USD","LU0965509283.SGD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU1934455277.USD","LU1989772840.SGD","IE0004445239.USD","LU2023251221.USD","LU2237443382.USD","SG9999015978.USD","LU0128525929.USD","IE00BJT1NW94.SGD","LU1267930573.SGD","LU1291159041.SGD","ABBV"],"gpt_icon":0},{"id":"2503307339","title":"【先声药业(02096.HK)附属与AbbVie就SIM0500订立海外许可选择权协议】先声药业(02096.HK)公布，于2025年1月13日，该集团附属公司山东先声生物制药有限公司(山东先声)与AbbVie Inc.(股票代码：ABBV)的附属公司订立许可选择权协议。根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤(MM)患者进行临床I期研究。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503307339","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503307339?lang=zh_cn&edition=fundamental","pubTime":"2025-01-13 21:57","pubTimestamp":1736776666,"startTime":"0","endTime":"0","summary":"先声药业(02096.HK)公布，于2025年1月13日，该集团附属公司山东先声生物制药有限公司(山东先声)与AbbVie Inc.(股票代码：ABBV)的附属公司订立许可选择权协议。根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤(MM)患者进行临床I期研究。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/13215747401967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SG9999015952.SGD","LU0912757837.SGD","LU1291159041.SGD","LU2237443465.HKD","LU0128525929.USD","LU1037948897.HKD","LU2023251221.USD","LU0256863811.USD","LU0198837287.USD","LU0965508806.USD","02096","IE00B2B36J28.USD","IE00BGHQF631.EUR","BK1583","LU2089283258.USD","LU2089984988.USD","LU1585245621.USD","LU0965509010.AUD","LU1989772840.SGD","LU0114720955.EUR","LU0820561909.HKD","BK4581","IE00B3PB1722.GBP","IE0004445239.USD","LU1989772923.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","BK4550","LU0310799852.SGD","LU0689472784.USD","LU1430594728.SGD","LU2237443549.SGD","LU1496350171.SGD","SG9999003800.SGD","LU0661504455.SGD","LU1037948541.HKD","LU0203347892.USD","LU1718418525.SGD","LU0234570918.USD","LU0158827948.USD","IE0002141913.USD","LU2133065610.SGD","LU0211328371.USD","SG9999015978.USD","LU0456855351.SGD","LU0256863902.USD","LU0985320562.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","ABBV"],"gpt_icon":0},{"id":"2502705063","title":"2025年买什么？从电动车到美妆，策略师看好四大潜力股","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705063","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502705063?lang=zh_cn&edition=fundamental","pubTime":"2025-01-09 13:21","pubTimestamp":1736400069,"startTime":"0","endTime":"0","summary":"“2025年的股市可能会波动，但专注于个股选择的投资者将迎来重大机会，”Marketgauge.com的首席市场策略师Michele Schneider表示。从美妆品牌到电动车公司，以下是Schneider预计今年将跑赢市场的四只股票。Ulta Beauty的股价在过去12个月下跌了约9.4%。经历了艰难的2024年，Rivian在过去12个月下跌了近35%。根据FactSet的数据，其平均目标价为14.83美元，意味着有11.9%的上涨潜力。Schneider表示，Chewy因其客户服务而闻名，目前正在扩大服务范围，包括处方药和宠物保险。Chewy在过去12个月上涨了超过60%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/01/09132147288704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0949170772.SGD","LU0965509101.SGD","LU0553294199.USD","BK4566","IE00BSNM7G36.USD","LU0198837287.USD","LU0545039389.USD","LU2087621335.USD","BK4559","LU0820561909.HKD","RIVN","LU0820561818.USD","ULTA","LU0256863902.USD","LU0738911758.USD","LU0985320562.USD","LU1430594728.SGD","BK4099","CHWY","SG9999015978.USD","LU2023251221.USD","BK4555","LU1037948897.HKD","SG9999003800.SGD","LU0203347892.USD","LU0234570918.USD","BK4548","SG9999001440.SGD","LU2133065610.SGD","LU1585245621.USD","LU2237443978.SGD","ABBV","IE00B2B36J28.USD","LU1267930573.SGD","IE00BFTCPJ56.SGD","LU1496350171.SGD","IE00B3PB1722.GBP","BK4547","BK4122","LU1732800096.USD","IE00B42XCP33.USD","LU0211328371.USD","LU1718418525.SGD","IE0002141913.USD","BK4200","LU1839511570.USD","LU1934455277.USD","IE0004445239.USD","LU0114720955.EUR","IE0009355771.USD"],"gpt_icon":1},{"id":"2501205516","title":"BUZZ-贝伦贝格称，肥胖症药物和并购是 2025 年制药业的主要驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2501205516","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501205516?lang=zh_cn&edition=fundamental","pubTime":"2025-01-07 20:55","pubTimestamp":1736254525,"startTime":"0","endTime":"0","summary":"    1月7日 - ** 贝伦贝格在其 2025 年制药业展望中指出，肥胖症药物将成为管道新闻的主要内容，而中国的特定股票问题应开始缓解** 贝伦贝格认为，肥胖症药物生产商的销售额将增长 26%，其中新兴的口服治疗药物将受到密切关注，而未涉足减肥治疗药物的生产商的销售额增长将放缓。** 它还预计今年将出现并购热潮，约有 570 亿美元的未分配现金可供其覆盖的公司用于并购和业务发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU1732799900.SGD","LU2602419157.SGD","IE00BJT1NW94.SGD","SG9999011175.SGD","LU1032466523.USD","LU0061475181.USD","LU0985481810.HKD","BK4534","IE000M9KFDE8.USD","LU1066053197.SGD","SG9999014914.USD","SG9999015358.SGD","IE00B2B36J28.USD","LU0203202063.USD","BK4585","IE00B1BXHZ80.USD","LU2361045086.USD","PFE","LU0006306889.USD","BK4007","LU2125154935.USD","LU1983299246.USD","LU2468319806.SGD","LU0965508806.USD","LU0122379950.USD","LU1670711123.USD","LU1093756325.SGD","SG9999015952.SGD","LU0708995401.HKD","LU2242646821.SGD","IE00BDGV0183.EUR","SG9999018857.SGD","LLY","LU0882574055.USD","LU1868836914.USD","LU2360106947.USD","LU1585245621.USD","LU1989772923.USD","GB00BDT5M118.USD","LU2491050154.USD","LU2089984988.USD","BK4532","SGXZ31699556.SGD","LU1974910355.USD","LU2491049909.HKD","MRK","IE00BLSP4452.SGD","BMY","ABBV"],"gpt_icon":1},{"id":"2501213387","title":"艾伯维下调2024财年盈测 低于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2501213387","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501213387?lang=zh_cn&edition=fundamental","pubTime":"2025-01-07 09:00","pubTimestamp":1736211623,"startTime":"0","endTime":"0","summary":"格隆汇1月7日｜美国生物技术公司艾伯维下调2024财年调整后的每股盈利预测，由原先的10.9-10.94美元降至10.02-10.06美元，不及市场平均预期的10.94美元，因里程碑付款以及研究与开发成本相关的费用达到16亿美元。艾伯维预计第四季调整后每股盈利介乎2.06-2.1美元，去年同期为2.79美元。公司计划于1月31日公布第四季业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010709003595fae90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010709003595fae90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE0004445239.USD","LU2237443895.HKD","BK4559","IE00BVYPNV92.GBP","LU1496350502.SGD","LU2089283258.USD","LU2237443382.USD","LU1989772923.USD","LU0965509101.SGD","LU0256863902.USD","LU1551013425.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU2347655156.SGD","LU2468319806.SGD","LU0029864427.USD","BK4585","ABBV","LU0661504455.SGD","LU0795875086.SGD","LU1037948897.HKD","LU1718418525.SGD","LU1989771016.USD","LU2237443465.HKD","IE0002141913.USD","BK4581","LU0553294199.USD","LU0170899867.USD","LU0545039389.USD","LU1023059063.AUD","LU0198837287.USD","LU1934455863.HKD","LU0114720955.EUR","LU2089284900.SGD","IE00B42XCP33.USD","LU0689472784.USD","LU2237443978.SGD","LU1093756325.SGD","LU1732799900.SGD","LU1061106388.HKD","LU2087621335.USD","SG9999011175.SGD","SG9999015952.SGD","LU1430594728.SGD","LU1839511570.USD","LU1291159041.SGD","LU1244550221.USD","LU0820561909.HKD","LU1934455194.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":170,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABBV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-25","symbol":"ABBV","fiscalQuarterEnding":"2025/03","expectedEps":2.39,"name":null,"time":"盘前","type":"earning","dateTimestamp":1745553600000,"reportTimeType":"pre","actualEps":2.46},{"date":"2025-04-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-15","defaultRemindTime":1744723800000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-15","currency":"USD","dateTimestamp":1744689600000,"payDate":"2025-05-15"},{"market":"US","date":"2025-01-31","symbol":"ABBV","fiscalQuarterEnding":"2024/12","expectedEps":2.13,"name":null,"time":"盘前","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":2.16},{"date":"2025-01-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-15","defaultRemindTime":1736951400000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-14","payableDate":"2025-01-15","currency":"USD","dateTimestamp":1736917200000,"payDate":"2025-02-14"},{"date":"2024-10-30","symbol":"ABBV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":2.95,"defaultRemindTime":1730275200000,"name":null,"time":"盘前","dateTimestamp":1730260800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABBV\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-13","recordDate":"2015-07-15","paymentDate":"2015-08-14","value":0.51,"currency":"USD"},{"executeDate":"2015-10-13","recordDate":"2015-10-15","paymentDate":"2015-11-16","value":0.51,"currency":"USD"},{"executeDate":"2016-01-13","recordDate":"2016-01-15","paymentDate":"2016-02-16","value":0.57,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-05-16","value":0.57,"currency":"USD"},{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-08-15","value":0.57,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABBV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.3929,"hold":0.3571,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3929,"analysts":28,"updateTime":1747281600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABBV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABBV","date":"2025-06-11","current":79.793414,"percent":0.965854,"low":18.777893,"twenty":21.834009,"median":30.969586,"eighty":60.159363,"high":89.406682,"avg":37.957232,"sd":18.528952,"marketCap":334733373616},"quantilePoints":[{"date":"2020-06-12","current":19.315572,"twenty":20.733606,"median":24.800604,"eighty":35.971396,"marketCap":162946161198},{"date":"2020-06-19","current":20.203428,"twenty":20.654787,"median":24.775189,"eighty":35.971396,"marketCap":170436115612},{"date":"2020-06-26","current":20.082261,"twenty":20.59993,"median":24.728312,"eighty":35.971396,"marketCap":169413957127},{"date":"2020-07-02","current":20.656757,"twenty":20.591745,"median":24.665358,"eighty":35.971396,"marketCap":174260398219},{"date":"2020-07-10","current":20.228497,"twenty":20.552719,"median":24.589678,"eighty":35.971396,"marketCap":170647596678},{"date":"2020-07-17","current":21.064126,"twenty":20.544707,"median":24.552451,"eighty":35.971396,"marketCap":177696965538},{"date":"2020-07-24","current":20.286991,"twenty":20.488542,"median":24.477697,"eighty":35.971396,"marketCap":171141052498},{"date":"2020-07-31","current":24.042533,"twenty":20.471609,"median":24.448767,"eighty":35.971396,"marketCap":167263899625},{"date":"2020-08-07","current":23.571698,"twenty":20.471609,"median":24.400797,"eighty":35.971396,"marketCap":163988305218},{"date":"2020-08-14","current":24.117105,"twenty":20.471609,"median":24.360108,"eighty":35.971396,"marketCap":167782696697},{"date":"2020-08-21","current":24.063832,"twenty":20.471609,"median":24.316683,"eighty":35.971396,"marketCap":167412081715},{"date":"2020-08-28","current":23.888795,"twenty":20.471609,"median":24.278909,"eighty":35.971396,"marketCap":166194346775},{"date":"2020-09-04","current":23.305337,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":162135230310},{"date":"2020-09-11","current":22.754857,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":158305542166},{"date":"2020-09-18","current":22.858865,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":159029123797},{"date":"2020-09-25","current":21.874597,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152181570802},{"date":"2020-10-02","current":21.846692,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":151987439145},{"date":"2020-10-09","current":22.247503,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":154775875674},{"date":"2020-10-16","current":21.884744,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152252164132},{"date":"2020-10-23","current":21.395147,"twenty":20.472699,"median":24.256547,"eighty":35.971396,"marketCap":148846035967},{"date":"2020-10-30","current":20.347827,"twenty":20.466853,"median":24.256547,"eighty":35.971396,"marketCap":150187309234},{"date":"2020-11-06","current":22.208949,"twenty":20.466853,"median":24.228983,"eighty":35.971396,"marketCap":163924253750},{"date":"2020-11-13","current":23.689546,"twenty":20.466853,"median":24.164263,"eighty":35.971396,"marketCap":174852537333},{"date":"2020-11-20","current":24.120091,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":178030390395},{"date":"2020-11-27","current":25.088817,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":185180559783},{"date":"2020-12-04","current":25.660485,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":189400042459},{"date":"2020-12-11","current":25.435645,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":187740496971},{"date":"2020-12-18","current":24.983573,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":184403751257},{"date":"2020-12-24","current":24.698935,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":182302837288},{"date":"2020-12-31","current":25.62939,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189170530849},{"date":"2021-01-08","current":25.658093,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189382387720},{"date":"2021-01-15","current":26.435466,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195120177969},{"date":"2021-01-22","current":26.516792,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195720439103},{"date":"2021-01-29","current":24.512365,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":180925767629},{"date":"2021-02-05","current":41.585784,"twenty":20.466853,"median":24.227431,"eighty":36.040882,"marketCap":191959979647},{"date":"2021-02-12","current":39.944995,"twenty":20.466853,"median":24.256547,"eighty":36.146771,"marketCap":184386096518},{"date":"2021-02-19","current":40.172278,"twenty":20.466853,"median":24.287457,"eighty":36.294777,"marketCap":185435236266},{"date":"2021-02-26","current":41.216658,"twenty":20.466853,"median":24.337426,"eighty":36.404226,"marketCap":190256093280},{"date":"2021-03-05","current":40.818799,"twenty":20.466178,"median":24.378392,"eighty":36.750131,"marketCap":188419576323},{"date":"2021-03-12","current":41.400285,"twenty":20.466178,"median":24.379616,"eighty":36.795798,"marketCap":191103716491},{"date":"2021-03-19","current":39.564013,"twenty":20.466178,"median":24.409847,"eighty":36.844037,"marketCap":182627484379},{"date":"2021-03-26","current":40.519116,"twenty":20.466853,"median":24.44121,"eighty":37.032995,"marketCap":187036238813},{"date":"2021-04-01","current":41.490229,"twenty":20.466853,"median":24.44121,"eighty":37.085025,"marketCap":191518896358},{"date":"2021-04-09","current":41.115547,"twenty":20.466178,"median":24.440608,"eighty":37.16205,"marketCap":189789367069},{"date":"2021-04-16","current":41.257009,"twenty":20.466178,"median":24.440608,"eighty":37.259163,"marketCap":190442352617},{"date":"2021-04-23","current":42.583687,"twenty":20.466178,"median":24.440608,"eighty":37.311305,"marketCap":196566298160},{"date":"2021-04-30","current":38.142678,"twenty":20.466178,"median":24.440608,"eighty":37.626818,"marketCap":196778077257},{"date":"2021-05-07","current":39.62788,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":204440235392},{"date":"2021-05-14","current":39.860684,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205641266580},{"date":"2021-05-21","current":39.754553,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205093737656},{"date":"2021-05-28","current":38.754869,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199936368435},{"date":"2021-06-04","current":38.467289,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":198452741672},{"date":"2021-06-11","current":39.514903,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203857382021},{"date":"2021-06-18","current":38.72748,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199795070648},{"date":"2021-06-25","current":38.67955,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199547799521},{"date":"2021-07-02","current":39.429313,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203415826437},{"date":"2021-07-09","current":39.912037,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205906199930},{"date":"2021-07-16","current":40.227006,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":207531124480},{"date":"2021-07-23","current":40.463233,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":208749817891},{"date":"2021-07-30","current":30.828704,"twenty":20.466178,"median":24.440608,"eighty":37.719322,"marketCap":205411657676},{"date":"2021-08-06","current":30.354681,"twenty":20.466178,"median":24.440608,"eighty":37.391572,"marketCap":202253239637},{"date":"2021-08-13","current":30.893082,"twenty":20.466178,"median":24.440608,"eighty":37.288928,"marketCap":205840605967},{"date":"2021-08-20","current":31.513702,"twenty":20.466178,"median":24.440608,"eighty":37.212873,"marketCap":209975796712},{"date":"2021-08-27","current":31.715271,"twenty":20.466178,"median":24.440608,"eighty":37.144732,"marketCap":211318850116},{"date":"2021-09-03","current":29.604102,"twenty":20.466178,"median":24.440608,"eighty":37.055599,"marketCap":197252132881},{"date":"2021-09-10","current":28.293905,"twenty":20.466178,"median":24.440608,"eighty":36.9642,"marketCap":188522285753},{"date":"2021-09-17","current":28.572388,"twenty":20.466178,"median":24.440608,"eighty":36.820278,"marketCap":190377820062},{"date":"2021-09-24","current":28.397341,"twenty":20.466178,"median":24.440608,"eighty":36.787789,"marketCap":189211484211},{"date":"2021-10-01","current":28.93309,"twenty":20.466178,"median":24.440608,"eighty":36.538082,"marketCap":192781178785},{"date":"2021-10-08","current":29.487404,"twenty":20.466178,"median":24.440608,"eighty":36.364331,"marketCap":196474575647},{"date":"2021-10-15","current":28.996743,"twenty":20.466178,"median":24.440608,"eighty":36.272778,"marketCap":193205300913},{"date":"2021-10-22","current":28.946351,"twenty":20.466178,"median":24.440608,"eighty":36.089393,"marketCap":192869537562},{"date":"2021-10-29","current":26.897003,"twenty":20.466178,"median":24.440608,"eighty":35.979473,"marketCap":202642018254},{"date":"2021-11-05","current":27.496713,"twenty":20.466178,"median":24.440608,"eighty":35.893834,"marketCap":207160232888},{"date":"2021-11-12","current":27.447435,"twenty":20.466178,"median":24.440608,"eighty":35.826686,"marketCap":206788977991},{"date":"2021-11-19","current":27.276138,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205498425251},{"date":"2021-11-26","current":27.339495,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205975752977},{"date":"2021-12-03","current":27.888584,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":210112593265},{"date":"2021-12-10","current":29.441991,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":221815961943},{"date":"2021-12-17","current":30.394685,"twenty":20.466178,"median":24.440608,"eighty":35.716411,"marketCap":228993556631},{"date":"2021-12-23","current":31.230052,"twenty":20.466178,"median":24.440608,"eighty":35.617966,"marketCap":235287211086},{"date":"2021-12-31","current":31.772102,"twenty":20.466178,"median":24.440608,"eighty":35.49234,"marketCap":239371014961},{"date":"2022-01-07","current":31.650082,"twenty":20.466853,"median":24.44121,"eighty":35.38963,"marketCap":238451717119},{"date":"2022-01-14","current":31.882389,"twenty":20.466853,"median":24.44121,"eighty":35.300366,"marketCap":240201918779},{"date":"2022-01-21","current":30.969586,"twenty":20.466853,"median":24.44121,"eighty":35.215099,"marketCap":233324863770},{"date":"2022-01-28","current":32.363429,"twenty":20.466853,"median":24.44121,"eighty":35.13817,"marketCap":243826073732},{"date":"2022-02-04","current":21.543267,"twenty":20.466853,"median":24.379004,"eighty":35.104764,"marketCap":248652387402},{"date":"2022-02-11","current":21.751577,"twenty":20.466853,"median":24.314673,"eighty":35.095534,"marketCap":251056704834},{"date":"2022-02-18","current":22.071878,"twenty":20.466853,"median":24.256547,"eighty":34.992103,"marketCap":254753613990},{"date":"2022-02-25","current":22.916258,"twenty":20.466853,"median":24.228983,"eighty":34.873074,"marketCap":264499447588},{"date":"2022-03-04","current":23.072568,"twenty":20.466853,"median":24.117673,"eighty":34.437795,"marketCap":266303576494},{"date":"2022-03-11","current":22.8427,"twenty":20.466853,"median":24.068013,"eighty":34.07367,"marketCap":263650445750},{"date":"2022-03-18","current":24.396605,"twenty":20.466853,"median":24.030352,"eighty":33.659591,"marketCap":281585609576},{"date":"2022-03-25","current":24.688507,"twenty":20.466853,"median":24.030352,"eighty":33.444136,"marketCap":284954746788},{"date":"2022-04-01","current":24.895099,"twenty":20.466853,"median":24.030352,"eighty":32.161158,"marketCap":287339231436},{"date":"2022-04-08","current":26.774321,"twenty":20.466853,"median":24.030352,"eighty":32.010235,"marketCap":309029210303},{"date":"2022-04-14","current":24.838477,"twenty":20.466853,"median":24.030352,"eighty":31.911234,"marketCap":286685706014},{"date":"2022-04-22","current":23.71829,"twenty":20.466853,"median":23.990825,"eighty":31.773041,"marketCap":273756500370},{"date":"2022-04-29","current":20.789481,"twenty":20.466853,"median":23.93685,"eighty":31.728457,"marketCap":259431929637},{"date":"2022-05-06","current":21.641753,"twenty":20.471609,"median":23.919764,"eighty":31.65145,"marketCap":270067433984},{"date":"2022-05-13","current":21.736629,"twenty":20.49488,"median":23.919764,"eighty":31.65145,"marketCap":271251397740},{"date":"2022-05-20","current":21.384029,"twenty":20.584423,"median":23.919764,"eighty":31.65145,"marketCap":266851293633},{"date":"2022-05-27","current":21.241006,"twenty":20.63248,"median":23.919764,"eighty":31.65145,"marketCap":265066512450},{"date":"2022-06-03","current":20.840259,"twenty":20.656606,"median":23.919764,"eighty":31.65145,"marketCap":260065590915},{"date":"2022-06-10","current":20.27808,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":253050163885},{"date":"2022-06-17","current":19.581375,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":244355982277},{"date":"2022-06-24","current":21.572366,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":269201550044},{"date":"2022-07-01","current":21.779111,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271781530765},{"date":"2022-07-08","current":21.644585,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":270102776186},{"date":"2022-07-15","current":21.753622,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271463450950},{"date":"2022-07-22","current":21.024348,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":262362834023},{"date":"2022-07-29","current":20.067893,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":253597968011},{"date":"2022-08-05","current":19.313764,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":244068040169},{"date":"2022-08-12","current":19.951773,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":252130560187},{"date":"2022-08-19","current":19.846838,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":250804487815},{"date":"2022-08-26","current":19.077309,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":241079957093},{"date":"2022-09-02","current":19.067515,"twenty":20.656456,"median":23.920291,"eighty":31.652818,"marketCap":240956190338},{"date":"2022-09-09","current":19.786675,"twenty":20.595877,"median":23.920291,"eighty":31.652818,"marketCap":250044206322},{"date":"2022-09-16","current":20.156048,"twenty":20.476993,"median":23.900397,"eighty":31.652818,"marketCap":254711981069},{"date":"2022-09-23","current":20.016134,"twenty":20.455391,"median":23.887831,"eighty":31.652818,"marketCap":252943884574},{"date":"2022-09-30","current":18.777893,"twenty":20.415192,"median":23.86089,"eighty":31.652818,"marketCap":237296230593},{"date":"2022-10-07","current":19.414503,"twenty":20.32543,"median":23.832384,"eighty":31.652818,"marketCap":245341069646},{"date":"2022-10-14","current":19.999344,"twenty":20.291044,"median":23.721085,"eighty":31.652818,"marketCap":252731712995},{"date":"2022-10-21","current":20.575791,"twenty":20.264429,"median":23.655412,"eighty":31.652818,"marketCap":260016270554},{"date":"2022-10-28","current":19.464223,"twenty":20.259089,"median":23.613004,"eighty":31.652818,"marketCap":260956835438},{"date":"2022-11-04","current":19.156983,"twenty":20.231602,"median":23.54736,"eighty":31.652818,"marketCap":256837673955},{"date":"2022-11-11","current":19.800472,"twenty":20.186853,"median":23.498486,"eighty":31.652818,"marketCap":265464930624},{"date":"2022-11-18","current":20.436049,"twenty":20.140891,"median":23.460701,"eighty":31.652818,"marketCap":273986114465},{"date":"2022-11-25","current":21.047891,"twenty":20.140891,"median":23.4195,"eighty":31.652818,"marketCap":282189079823},{"date":"2022-12-02","current":21.580616,"twenty":20.140891,"median":23.312456,"eighty":31.652818,"marketCap":289331316901},{"date":"2022-12-09","current":21.501498,"twenty":20.140891,"median":23.254346,"eighty":31.652818,"marketCap":288270588622},{"date":"2022-12-16","current":21.161293,"twenty":20.140891,"median":23.143047,"eighty":31.652818,"marketCap":283709457023},{"date":"2022-12-23","current":21.506773,"twenty":20.140891,"median":23.049581,"eighty":31.652818,"marketCap":288341303841},{"date":"2022-12-30","current":21.310298,"twenty":20.140891,"median":22.955262,"eighty":31.652818,"marketCap":285707161948},{"date":"2023-01-06","current":21.961698,"twenty":20.140891,"median":22.924243,"eighty":31.652818,"marketCap":294440491445},{"date":"2023-01-13","current":20.254079,"twenty":20.128039,"median":22.88677,"eighty":31.652818,"marketCap":271546439424},{"date":"2023-01-20","current":19.725311,"twenty":20.087275,"median":22.858865,"eighty":31.652818,"marketCap":264457238759},{"date":"2023-01-27","current":19.288846,"twenty":20.063902,"median":22.808986,"eighty":31.58391,"marketCap":258605554420},{"date":"2023-02-03","current":19.146434,"twenty":20.02201,"median":22.751914,"eighty":31.360556,"marketCap":256696243518},{"date":"2023-02-10","current":22.710901,"twenty":20.005604,"median":22.710901,"eighty":31.151136,"marketCap":268806224703},{"date":"2023-02-17","current":22.619796,"twenty":20.005604,"median":22.66283,"eighty":30.904912,"marketCap":267727909612},{"date":"2023-02-24","current":22.829087,"twenty":20.005604,"median":22.645014,"eighty":30.684887,"marketCap":270205069571},{"date":"2023-03-03","current":23.329888,"twenty":20.005604,"median":22.645014,"eighty":30.504652,"marketCap":276132559474},{"date":"2023-03-10","current":22.380607,"twenty":20.005604,"median":22.619796,"eighty":30.197139,"marketCap":264896869658},{"date":"2023-03-17","current":23.054821,"twenty":20.005604,"median":22.619796,"eighty":29.636874,"marketCap":272876863527},{"date":"2023-03-24","current":23.552694,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":278769685181},{"date":"2023-03-31","current":23.75391,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":281151276594},{"date":"2023-04-06","current":23.96705,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":283673999349},{"date":"2023-04-14","current":24.248752,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":287008227327},{"date":"2023-04-21","current":24.107156,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":285332292629},{"date":"2023-04-28","current":34.624626,"twenty":20.005604,"median":22.619796,"eighty":29.534083,"marketCap":262627787830},{"date":"2023-05-05","current":34.273426,"twenty":20.003999,"median":22.619394,"eighty":29.832035,"marketCap":259963933732},{"date":"2023-05-12","current":34.097195,"twenty":20.003999,"median":22.619394,"eighty":30.429562,"marketCap":258627224191},{"date":"2023-05-19","current":33.364497,"twenty":20.003999,"median":22.619394,"eighty":30.595519,"marketCap":253069711699},{"date":"2023-05-26","current":32.243353,"twenty":20.003999,"median":22.619394,"eighty":30.868682,"marketCap":244565835441},{"date":"2023-06-02","current":31.038473,"twenty":20.003999,"median":22.619394,"eighty":31.001499,"marketCap":235426814899},{"date":"2023-06-09","current":32.015403,"twenty":20.003999,"median":22.619394,"eighty":31.230052,"marketCap":242836831555},{"date":"2023-06-16","current":31.608349,"twenty":20.003999,"median":22.619394,"eighty":31.499834,"marketCap":239749324615},{"date":"2023-06-23","current":31.961904,"twenty":20.002393,"median":22.619796,"eighty":31.594638,"marketCap":242431044928},{"date":"2023-06-30","current":30.989626,"twenty":20.000788,"median":22.674437,"eighty":31.615327,"marketCap":235056314066},{"date":"2023-07-07","current":31.924688,"twenty":20.000788,"median":22.719209,"eighty":31.656922,"marketCap":242148758580},{"date":"2023-07-14","current":31.073363,"twenty":20.000788,"median":22.725831,"eighty":31.656922,"marketCap":235691458351},{"date":"2023-07-21","current":33.073744,"twenty":20.000788,"median":22.747044,"eighty":31.715785,"marketCap":250864349599},{"date":"2023-07-28","current":30.237711,"twenty":20.000788,"median":22.794968,"eighty":31.73628,"marketCap":262614518868},{"date":"2023-08-04","current":30.278339,"twenty":20.000788,"median":22.840032,"eighty":31.73628,"marketCap":262967376804},{"date":"2023-08-11","current":30.777049,"twenty":20.000788,"median":22.876107,"eighty":31.73628,"marketCap":267298669219},{"date":"2023-08-18","current":30.488463,"twenty":20.000788,"median":22.903399,"eighty":31.73628,"marketCap":264792302933},{"date":"2023-08-25","current":29.799516,"twenty":20.000499,"median":22.912503,"eighty":31.736322,"marketCap":258808794688},{"date":"2023-09-01","current":29.866581,"twenty":20.000499,"median":22.961834,"eighty":31.736322,"marketCap":259391260092},{"date":"2023-09-08","current":30.262879,"twenty":20.000499,"median":23.049581,"eighty":31.736322,"marketCap":262833101118},{"date":"2023-09-15","current":31.224153,"twenty":20.000499,"median":23.07874,"eighty":31.736322,"marketCap":271181771915},{"date":"2023-09-22","current":31.181475,"twenty":20.000499,"median":23.211789,"eighty":31.736322,"marketCap":270811112112},{"date":"2023-09-29","current":30.941665,"twenty":20.000499,"median":23.269501,"eighty":31.736322,"marketCap":268728357030},{"date":"2023-10-06","current":29.966164,"twenty":20.000499,"median":23.340513,"eighty":31.736322,"marketCap":260256132966},{"date":"2023-10-13","current":30.138909,"twenty":20.000499,"median":23.434713,"eighty":31.736322,"marketCap":261756422644},{"date":"2023-10-20","current":29.573931,"twenty":20.000499,"median":23.482911,"eighty":31.736322,"marketCap":256849592873},{"date":"2023-10-27","current":29.508898,"twenty":20.025934,"median":23.532342,"eighty":31.736447,"marketCap":256284777936},{"date":"2023-11-03","current":38.818021,"twenty":20.064885,"median":23.574586,"eighty":31.77145,"marketCap":252860587376},{"date":"2023-11-10","current":37.413998,"twenty":20.093125,"median":23.635568,"eighty":31.873171,"marketCap":243714785594},{"date":"2023-11-17","current":37.479047,"twenty":20.153246,"median":23.719687,"eighty":31.93114,"marketCap":244138514575},{"date":"2023-11-24","current":37.584752,"twenty":20.203428,"median":23.764425,"eighty":31.993004,"marketCap":244827074170},{"date":"2023-12-01","current":38.593011,"twenty":20.233906,"median":23.836611,"eighty":32.031772,"marketCap":251394873376},{"date":"2023-12-08","current":40.105399,"twenty":20.254383,"median":23.887831,"eighty":32.111411,"marketCap":261246572185},{"date":"2023-12-15","current":41.978268,"twenty":20.281644,"median":23.913883,"eighty":32.197857,"marketCap":273446435764},{"date":"2023-12-22","current":41.357592,"twenty":20.317955,"median":23.921773,"eighty":32.898827,"marketCap":269403355070},{"date":"2023-12-29","current":41.943033,"twenty":20.358981,"median":23.957161,"eighty":33.273317,"marketCap":273216915899},{"date":"2024-01-05","current":43.761694,"twenty":20.423435,"median":24.01817,"eighty":33.364497,"marketCap":285063671994},{"date":"2024-01-12","current":44.3905,"twenty":20.460384,"median":24.053498,"eighty":34.097195,"marketCap":289159718811},{"date":"2024-01-19","current":44.260402,"twenty":20.478089,"median":24.095977,"eighty":34.278187,"marketCap":288312260849},{"date":"2024-01-26","current":44.756401,"twenty":20.553124,"median":24.120091,"eighty":35.147938,"marketCap":291543194329},{"date":"2024-02-02","current":45.423153,"twenty":20.593863,"median":24.228723,"eighty":37.173308,"marketCap":295886416385},{"date":"2024-02-09","current":63.458418,"twenty":20.593863,"median":24.25849,"eighty":37.413998,"marketCap":308598285816},{"date":"2024-02-16","current":64.111917,"twenty":20.593863,"median":24.303452,"eighty":37.487178,"marketCap":311776253174},{"date":"2024-02-23","current":64.204023,"twenty":20.593863,"median":24.387036,"eighty":37.584752,"marketCap":312224166203},{"date":"2024-03-01","current":63.94975,"twenty":20.619083,"median":24.46262,"eighty":37.685479,"marketCap":310987634851},{"date":"2024-03-08","current":65.59163,"twenty":20.675521,"median":24.520094,"eighty":38.122626,"marketCap":318972094434},{"date":"2024-03-15","current":65.820476,"twenty":20.718499,"median":24.641098,"eighty":38.309656,"marketCap":320084972650},{"date":"2024-03-22","current":64.628797,"twenty":20.718499,"median":24.761685,"eighty":38.446792,"marketCap":314289839482},{"date":"2024-03-28","current":65.666499,"twenty":20.727926,"median":24.813227,"eighty":38.489808,"marketCap":319336183384},{"date":"2024-04-05","current":61.13338,"twenty":20.724828,"median":24.923775,"eighty":38.67955,"marketCap":297291628445},{"date":"2024-04-12","current":60.99502,"twenty":20.724828,"median":25.009872,"eighty":38.740116,"marketCap":296618782592},{"date":"2024-04-19","current":59.953677,"twenty":20.749631,"median":25.058842,"eighty":38.963687,"marketCap":291554732220},{"date":"2024-04-26","current":60.911276,"twenty":20.790512,"median":25.196454,"eighty":39.089597,"marketCap":296211533786},{"date":"2024-05-03","current":47.511721,"twenty":20.790512,"median":25.385187,"eighty":39.260827,"marketCap":284737741336},{"date":"2024-05-10","current":47.262672,"twenty":20.790512,"median":25.595836,"eighty":39.281414,"marketCap":283245192072},{"date":"2024-05-17","current":48.426559,"twenty":20.790512,"median":25.708617,"eighty":39.35331,"marketCap":290220369807},{"date":"2024-05-24","current":46.63211,"twenty":20.790512,"median":25.889623,"eighty":39.401951,"marketCap":279466235021},{"date":"2024-05-31","current":46.057533,"twenty":20.790512,"median":26.008509,"eighty":39.514903,"marketCap":276022792848},{"date":"2024-06-07","current":49.670004,"twenty":20.790512,"median":26.275101,"eighty":39.598251,"marketCap":297672331843},{"date":"2024-06-14","current":49.077747,"twenty":20.789481,"median":26.435348,"eighty":39.621033,"marketCap":294122937603},{"date":"2024-06-21","current":50.718976,"twenty":20.787742,"median":26.51701,"eighty":39.664583,"marketCap":303958821143},{"date":"2024-06-28","current":49.793759,"twenty":20.844337,"median":26.686669,"eighty":39.682345,"marketCap":298413996311},{"date":"2024-07-05","current":48.276285,"twenty":20.891877,"median":26.774321,"eighty":39.727716,"marketCap":289319777239},{"date":"2024-07-12","current":50.064841,"twenty":20.961971,"median":26.897003,"eighty":39.809021,"marketCap":300038594669},{"date":"2024-07-15","current":50.173864,"twenty":20.965963,"median":26.897106,"eighty":39.8291,"marketCap":300691965748},{"date":"2024-08-02","current":62.746353,"twenty":21.041401,"median":27.192211,"eighty":39.858924,"marketCap":335002776733},{"date":"2024-08-09","current":62.991543,"twenty":21.041401,"median":27.341842,"eighty":39.929328,"marketCap":336311849048},{"date":"2024-08-16","current":63.984057,"twenty":21.041401,"median":27.426316,"eighty":40.031862,"marketCap":341610880283},{"date":"2024-08-23","current":64.966646,"twenty":21.041401,"median":27.473717,"eighty":40.11022,"marketCap":346856921205},{"date":"2024-08-30","current":64.572949,"twenty":21.041401,"median":27.670608,"eighty":40.180948,"marketCap":344754972149},{"date":"2024-09-06","current":63.805405,"twenty":21.041401,"median":27.905087,"eighty":40.225134,"marketCap":340657054660},{"date":"2024-09-13","current":64.189177,"twenty":21.041401,"median":28.220968,"eighty":40.278795,"marketCap":342706013404},{"date":"2024-09-20","current":64.056841,"twenty":21.041401,"median":28.434472,"eighty":40.317815,"marketCap":341999475906},{"date":"2024-09-27","current":63.4878,"twenty":21.041401,"median":28.495473,"eighty":40.397704,"marketCap":338961364665},{"date":"2024-10-04","current":64.662275,"twenty":21.041401,"median":28.571062,"eighty":40.473352,"marketCap":345231884960},{"date":"2024-10-11","current":64.298353,"twenty":21.041401,"median":28.637367,"eighty":40.552864,"marketCap":343288906840},{"date":"2024-10-18","current":62.38611,"twenty":21.041401,"median":28.78987,"eighty":40.58204,"marketCap":333079439994},{"date":"2024-10-25","current":62.743415,"twenty":21.041401,"median":28.876067,"eighty":40.639084,"marketCap":334987091239},{"date":"2024-10-31","current":69.488142,"twenty":21.041401,"median":28.970221,"eighty":40.689185,"marketCap":355918264617},{"date":"2024-11-08","current":69.17792,"twenty":21.038157,"median":28.994091,"eighty":40.821941,"marketCap":354329306164},{"date":"2024-11-15","current":58.524017,"twenty":21.038157,"median":28.994091,"eighty":40.889808,"marketCap":299760012990},{"date":"2024-11-22","current":59.248537,"twenty":21.038157,"median":28.994091,"eighty":40.998263,"marketCap":303471007668},{"date":"2024-11-29","current":63.112647,"twenty":21.038157,"median":28.994091,"eighty":41.176214,"marketCap":323262979286},{"date":"2024-12-06","current":60.780381,"twenty":21.038157,"median":28.994091,"eighty":41.341004,"marketCap":311317110702},{"date":"2024-12-13","current":59.752252,"twenty":21.038157,"median":28.994091,"eighty":41.443897,"marketCap":306051032540},{"date":"2024-12-20","current":59.176085,"twenty":21.038157,"median":28.994091,"eighty":41.561559,"marketCap":303099908200},{"date":"2024-12-27","current":61.825761,"twenty":21.038157,"median":28.994091,"eighty":41.663666,"marketCap":316671545881},{"date":"2025-01-03","current":61.908563,"twenty":21.038157,"median":28.994091,"eighty":41.928939,"marketCap":317095659559},{"date":"2025-01-10","current":61.584254,"twenty":21.034912,"median":28.970221,"eighty":42.159599,"marketCap":315434547655},{"date":"2025-01-17","current":59.928207,"twenty":21.034912,"median":28.970221,"eighty":42.586745,"marketCap":306952274105},{"date":"2025-01-24","current":58.882827,"twenty":21.034912,"median":28.970221,"eighty":43.455963,"marketCap":301597838926},{"date":"2025-01-31","current":60.600976,"twenty":21.034912,"median":28.970221,"eighty":43.940578,"marketCap":310398197734},{"date":"2025-02-07","current":79.71133,"twenty":21.034912,"median":28.970221,"eighty":44.418688,"marketCap":341005068129},{"date":"2025-02-14","current":79.909606,"twenty":21.103138,"median":29.109583,"eighty":44.684847,"marketCap":341853295484},{"date":"2025-02-21","current":82.894924,"twenty":21.140099,"median":29.423589,"eighty":45.284381,"marketCap":354624484075},{"date":"2025-02-28","current":84.603332,"twenty":21.18493,"median":29.598162,"eighty":46.234326,"marketCap":361933053192},{"date":"2025-03-07","current":86.967867,"twenty":21.272159,"median":29.776497,"eighty":47.262672,"marketCap":372048536534},{"date":"2025-03-14","current":87.297994,"twenty":21.312935,"median":29.921453,"eighty":47.521968,"marketCap":373460820421},{"date":"2025-03-21","current":87.467185,"twenty":21.372316,"median":30.010192,"eighty":47.89618,"marketCap":374184615913},{"date":"2025-03-28","current":83.825918,"twenty":21.389415,"median":30.126715,"eighty":48.261552,"marketCap":358607276516},{"date":"2025-04-04","current":83.379331,"twenty":21.435567,"median":30.174737,"eighty":48.747733,"marketCap":356696779975},{"date":"2025-04-11","current":72.032729,"twenty":21.494114,"median":30.270609,"eighty":49.07539,"marketCap":308156016027},{"date":"2025-04-17","current":70.990694,"twenty":21.518555,"median":30.298444,"eighty":49.644664,"marketCap":303698190767},{"date":"2025-04-25","current":74.584061,"twenty":21.543267,"median":30.350267,"eighty":50.064841,"marketCap":319070612002},{"date":"2025-05-02","current":81.529025,"twenty":21.580616,"median":30.452813,"eighty":50.539236,"marketCap":342014260268},{"date":"2025-05-09","current":78.256732,"twenty":21.593607,"median":30.521771,"eighty":57.878848,"marketCap":328286988831},{"date":"2025-05-16","current":76.50062,"twenty":21.644585,"median":30.640885,"eighty":58.865001,"marketCap":320920101945},{"date":"2025-05-23","current":76.862743,"twenty":21.736629,"median":30.777049,"eighty":59.176085,"marketCap":322439208548},{"date":"2025-05-30","current":78.15965,"twenty":21.779111,"median":30.832081,"eighty":59.248537,"marketCap":327879729871},{"date":"2025-06-06","current":78.938635,"twenty":21.810057,"median":30.927439,"eighty":59.814353,"marketCap":331147575471},{"date":"2025-06-11","current":79.793414,"twenty":21.834009,"median":30.969586,"eighty":60.159363,"marketCap":334733373616}],"updateTime":1749732414487}}}